content

ArisGlobal Acquires Leading Regulatory Data Solution SPORIFY

ArisGlobal, a leading provider of life sciences software designed to automate core drug development functions with its end-to-end technology platform LifeSphereยฎ, today announces its...

Hyphens Pharma to develop and commercialise ByfavoR procedural sedation drug in Singapore

SGX-Catalist listed Hyphens Pharma International Limited, Singaporeโ€™s leading specialty pharmaceutical and consumer healthcare group, has just announced that its subsidiary, Hyphens Pharma Pte. Ltd.,...

AustinPx Expands Development, Manufacturing Technologies

AustinPx, a contract development and manufacturing organization (CDMO) specializing in analytical and formulation development services and cGMP manufacturing for small molecule drugs, expanded its...

Logistics innovations are key to fighting the next pandemic

The industry is using lessons learned during, to help eliminate underlying healthcare vulnerabilities and improve speed and efficiency of relief efforts The COVID-19 pandemic is...

FDA Discussion Paper On AI And ML Aiming Drug Development

A discussion paper has been published by the US FDA that aims at complementing and informing future guidance on artificial intelligence (AI) and machine...

Tablet Coatings Market Poised for Remarkable Growth by 2031

The worldwide tablet coatings sector generated $2.2 billion in 2021 and is projected to reach $4.1 billion by 2031, growing at a CAGR of...

EMA Lifts Business Continuity Measures Due To Pandemic Shift

The European Medicines Agency (EMA) and the European Medicines regulatory network have announced the lifting of COVID-19 business continuity measures, signifying a step towards...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read